Healthcare -
Biotechnology - NASDAQ - US
$ 243.34
-1.38 %
$ 31.5 B
Market Cap
-112.14
P/E
ALNY - PRE-TAX INCOME
Pre-tax Income ALNY - Alnylam Pharmaceuticals, Inc.
-179 M
LAST VALUE
60.15%
2 YEAR CAGR
27.37%
5 YEAR CAGR
7.74%
10 YEAR CAGR